• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchFibrobiologics
    Picture of Fibrobiologics logo

    FBLG — Fibrobiologics News Story

    $0.950.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    • Market Cap
      $6.61m
    • Enterprise Value
      $3.22m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • FBLG Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    FBLG Dividends
    All News

    NASDAQ RESUMED AT 09:00 AM

    Picture of Fibrobiologics logoFibrobiologics
    30/03/2026 14:00
    NASDAQ RESUMED  FBLG.O  AT 09:00 AM
    

    Recent news on Fibrobiologics

    See all news
    • Brief: Fibrobiologics Files Patent Application For Technology Designed To Produce Glp-1 And Other Therapeutic Peptides Inside The Body

      07/10/2026 13:48
    • Brief: Fibrobiologics Announces Chondrocyte Spheroids Demonstrate Cartilage Repair In Preclinical Study Of Degenerative Joints

      18/08/2026 13:31
    • U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil

      11/08/2026 19:07
    • U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,

      11/08/2026 16:44
    • Brief: Fibrobiologics Granted US Patent Covering The Use Of Fibroblasts

      11/08/2026 14:26

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.